123 related articles for article (PubMed ID: 1095213)
1. Specific MIF release by rat lymphocytes following incubation with syngeneic anti-tumor "immune" RNA.
Waldman SR; Pilch YH
Cell Immunol; 1975 Jul; 18(1):246-50. PubMed ID: 1095213
[No Abstract] [Full Text] [Related]
2. Stimulation of mouse migration inhibitory factor (MIF) production form MSV-immune lymphocytes by soluble tumor-associated antigen: requirement for histocompatible macrophages.
Landolfo S; Herberman RB; Holden HT
J Immunol; 1977 Apr; 118(4):1244-8. PubMed ID: 191532
[TBL] [Abstract][Full Text] [Related]
3. Identification of the principal cell type yielding immune RNA capable of transferring tumor-specific cellular cytotoxicity.
Wang BS; Onikul SR; Mannick JA
Cell Immunol; 1978 Aug; 39(1):27-35. PubMed ID: 699059
[No Abstract] [Full Text] [Related]
4. Macrophage-lymphocyte interaction in migration inhibition factor (MIF) production against soluble or cellular tumor-associated antigens. I. Characteristics and genetic control of two different mechanisms of stimulating MIF production.
Landolfo S; Herberman RB; Holden HT
J Immunol; 1978 Aug; 121(2):695-701. PubMed ID: 79613
[TBL] [Abstract][Full Text] [Related]
5. Immune cytolysis of rat tumor cells mediated by syngeneic "immune" RNA.
Kern DH; Drogemuller CR; Pilch YH
J Natl Cancer Inst; 1974 Jan; 52(1):299-302. PubMed ID: 4810971
[No Abstract] [Full Text] [Related]
6. Suppression of lymphokine production by macrophages infiltrating murine virus-induced tumors.
Varesio L; Herberman RB; Gerson JM; Holden HT
Int J Cancer; 1979 Jul; 24(1):97-102. PubMed ID: 314424
[TBL] [Abstract][Full Text] [Related]
7. Transfer of tumor immunity with RNA.
Pilch YH; Ramming KP; Deckers PJ
Isr J Med Sci; 1971 Jan; 7(1):246-58. PubMed ID: 5545768
[No Abstract] [Full Text] [Related]
8. Cellular immunity to murine sarcoma virus-induced tumors as measured by macrophage migration inhibition assays.
Landolfo S; Herberman RB; Holden HT
J Natl Cancer Inst; 1977 Dec; 59(6):1675-83. PubMed ID: 200758
[TBL] [Abstract][Full Text] [Related]
9. Mediation of immune responses to tumor antigens in vitro by immune RNA.
Kern DH; Drogemuller CR; Pilch YH
Ann N Y Acad Sci; 1976; 276():278-302. PubMed ID: 1071964
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between cytotoxic lymphocytes and cells that synthesize the macrophage migration inhibitory factor in the H-2 system].
Suslov AP; Egorova SG; Brondz BD
Biull Eksp Biol Med; 1975 Oct; 80(10):86-90. PubMed ID: 776251
[TBL] [Abstract][Full Text] [Related]
11. RNA extracts of lymphoid cells sensitized to DNP-oligolysines convert nonresponder lymphoid cells to responder cells which release migration inhibition factor.
Paque RE; Ali M; Dray S
Cell Immunol; 1975 Apr; 16(2):261-8. PubMed ID: 1090381
[No Abstract] [Full Text] [Related]
12. The role of immunoglobulin receptors on lymphocytes in production of MIF in guinea pigs.
Gościcka T
Cell Immunol; 1974 Aug; 13(2):207-15. PubMed ID: 4141646
[No Abstract] [Full Text] [Related]
13. Peritoneal macrophage response to leukemia L1210 in syngeneic mice.
Berd D; Prehn RT
J Natl Cancer Inst; 1977 Jun; 58(6):1729-34. PubMed ID: 864751
[No Abstract] [Full Text] [Related]
14. Immune interferon. II. Different cellular site for the production of murine macrophage migration inhibitory factor and interferon.
Neumann C; Sorg C
Eur J Immunol; 1978 Aug; 8(8):582-9. PubMed ID: 359337
[TBL] [Abstract][Full Text] [Related]
15. Antigen-mediated macrophage adherence inhibition.
Holán V; Hasek M; Bubeník J; Chutná J
Cell Immunol; 1974 Jul; 13(1):107-16. PubMed ID: 4141644
[No Abstract] [Full Text] [Related]
16. Two mechanisms of migration inhibition factor induction by tumour antigens.
Landolfo S; Herberman RB; Holden HT
Nature; 1977 Nov; 270(5632):62-4. PubMed ID: 337158
[No Abstract] [Full Text] [Related]
17. Solubilized tumour-associated antigens of methyl-cholanthrene-induced mouse sarcomas. Comparative studies by in vitro sensitization of lymph-node cells, macrophage electrophoretic mobility assay and transplantation tests.
Bubeník J; Indrová M; Nemecková S; Malkovský M; Von Broen B; Pálek V; Anderlíková J
Int J Cancer; 1978 Mar; 21(3):348-55. PubMed ID: 75857
[No Abstract] [Full Text] [Related]
18. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
[TBL] [Abstract][Full Text] [Related]
19. Detection of cellular immunity to tumor-associated antigen(s) in mice by the macrophage spreading inhibition test.
Svoboda I; Măzuran R; Rabatić S; Silobrcić
Int J Cancer; 1977 Mar; 19(3):371-7. PubMed ID: 844913
[TBL] [Abstract][Full Text] [Related]
20. Complete and apparently specif local tumor regression using syngeneic or xenogeneic "tumor-immune" RNA extracts.
Schlager SI; Paque RE; Dray S
Cancer Res; 1975 Aug; 35(8):1907-14. PubMed ID: 167938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
